Nestlé Health Science has made a strategic investment of $42.5 million in Pronutria Biosciences (Cambridge, MA, USA). Pronutria is pioneering a pipeline of oral therapeutic and nutritional biologics, called Pronutrein
Tag "Pronutrein"
The Magazine
Advertisements
